| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | VX-702 | GDSC1000 | pan-cancer | AAC | 0.0051 | 0.9 |
| mRNA | SR8278 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.9 |
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | 0.0053 | 0.9 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | 0.0043 | 0.9 |
| mRNA | JW-55 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.9 |
| mRNA | Tipifarnib | FIMM | pan-cancer | AAC | -0.018 | 0.9 |
| mRNA | ATRA | GDSC1000 | pan-cancer | AAC | -0.0044 | 0.9 |
| mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0042 | 0.9 |
| mRNA | apicidin | CTRPv2 | pan-cancer | AAC | -0.004 | 0.9 |
| mRNA | CD-1530 | CTRPv2 | pan-cancer | AAC | -0.0049 | 0.9 |